The cancer drug Gleevec The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment — with no signs of additional safety risks, a new study finds. Gleevec — known generically as imatinib — was hailed as a “wonder drug” when it was introduced in 2001 for treating chronic myeloid leukemia (CML)....